Stage III clinical trials aimed at evaluating the efficacy of Duloxetine in treating UI have demonstrated a highly significant decrease in the episodic frequency of incontinence [ 46 ] along with a significant improvement in symptoms among women suffering from mixed UI [ 47 ].
← all excerpts
Urinary incontinence: its assessment and relationship to depression among community-dwelling multiethnic older women.
1
—
—